Related Experiment Video
Updated: Jun 20, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Elevation of serum creatine phosphokinase in hospitalized patients
Khalil A Amir1, Sydney X Chen, Ravi K Bobba
1Geriatrics and Palliative Care, University of Virginia Health, Charlottesville, Virginia, USA.
Insights
Patients with elevated creatine phosphokinase (CPK) levels, whether cardiac or noncardiac, face significant mortality risks. Noncardiac CPK elevations are more common and have mortality rates comparable to cardiac elevations, with age and renal issues being key predictors.
Area of Science:
- Cardiology
- Biochemistry
- Clinical Medicine
Background:
- Clinical characteristics and outcomes of patients with significant serum creatine phosphokinase (CPK) elevations are not well described.
- Distinguishing between cardiac and noncardiac CPK elevations is crucial for understanding patient prognoses.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of patients with significant noncardiac and cardiac serum CPK elevations.
- To compare the mortality rates associated with noncardiac versus cardiac CPK elevations.
Main Methods:
- Retrospective analysis of 158 inpatients with CPK elevation >1000 IU/L.
- Included 137 patients with CPK elevations attributed to noncardiac or cardiac etiologies.
- Analyzed clinical characteristics and 30-day, 3-month, and 1-year all-cause mortality rates.
Main Results:
- Noncardiac CPK (NCCPK) elevation occurred in 69% of patients, while cardiac CPK (CCPK) elevation occurred in 31%.
- One-year mortality was 26.6% for NCCPK and 37.2% for CCPK.
- Older age, higher blood urea nitrogen, and creatinine levels were associated with increased mortality in both groups.
Conclusions:
- NCCPK elevation is more frequent than CCPK elevation in a veteran population.
- One-year mortality rates for NCCPK and CCPK elevations are comparable.
- Age and renal insufficiency are major predictors of mortality in patients with elevated CPK levels.
Background:
The clinical characteristics and outcomes of patients with significant noncardiac and cardiac serum creatine phosphokinase (CPK) elevations are not well described.
Methods:
One hundred fifty-eight inpatients who had CPK elevation of >1000 IU/L were identified. One hundred thirty-seven patients whose CPK elevations could be attributed to either noncardiac or cardiac etiologies were included and analyzed for clinical characteristics, 30-day, 3-month, and 1-year all-cause mortality rates. Twenty-one patients were excluded, in whom noncardiac and cardiac CPK (CCPK) elevations coexisted, or etiologies were unclear.
Results:
Of the 137 patients, 43 (31%) patients had CCPK elevation and 94 (69%) patients had noncardiac CPK (NCCPK) elevation. One-year mortality rate was 26.6% (25 of 94 patients) in NCCPK elevation group. Decedents were older (P < 0.05), had higher blood urea nitrogen (P < 0.01) and creatinine (P < 0.05) levels, and had higher white blood cell counts (P < 0.05) compared with survivors. In CCPK elevation group, 37.2% (16 of 43 patients) died within 1 year after admission. Decedents were also older (P < 0.01) and had higher blood urea nitrogen (P < 0.01) and creatinine (P < 0.01) levels.
Conclusion:
The incidence of NCCPK elevation is greater than that of CCPK elevation in a veteran, mostly male, population. One-year mortality rate in patients with NCCPK elevation is comparable to that in patients with CCPK elevation (26.6% versus 37.2%, P = 0.290). Age and renal insufficiency are 2 major predictors for increased mortality in both groups.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury I: Introduction
